Improve inhaler use, medication understanding, symptom awareness, and care continuity through multidisciplinary support between visits.
COPD and asthma are different diseases requiring individualized clinical management, but both can be undermined by similar between-visit problems: incorrect inhaler technique, inconsistent adherence, medication cost, exposure to triggers, delayed recognition of worsening symptoms, and incomplete follow-up after an exacerbation.
PharmD Live helps pulmonology and primary care practices, ACOs, IDNs, health systems, and payers address these gaps through condition-specific disease support, clinical pharmacist-led medication review, and social-needs coordination.
Patients receive education and follow-up aligned with the treating providerโs plan. The team reinforces symptom awareness, trigger identification, correct use of the personalized action plan, smoking-cessation goals when applicable, vaccination follow-up, and timely communication with the care team when symptoms worsen.
COPD and asthma workflows remain distinct and are aligned with the appropriate clinical guidance and provider-established plan.
Clinical pharmacists review controller and rescue medications, the complete medication list, adherence patterns, refill history when available, inhaler technique, potential interactions, side effects, and affordability barriers.
The pharmacist may identify opportunities to simplify the regimen, improve device selection, address adherence, or discuss guideline-aligned therapy with the prescriber. PharmD Live sends recommendations to the prescriber; the prescriber makes all prescribing and therapy-adjustment decisions.
The program identifies factors such as inhaler affordability, formulary restrictions, transportation, tobacco or indoor-air exposure, housing conditions, health literacy, digital access, and caregiver support. The team helps coordinate appropriate resources and communicates material barriers to the treating clinicians.
During an appropriate video interaction, the team can ask the patient to demonstrate how the device is prepared and used, identify observable technique concerns, provide education, and confirm understanding through return demonstration. The workflow depends on the device, patient capability, and program design.
No. Clinical pharmacists review medication use and send guideline-driven recommendations to the prescriber. The prescriber makes all medication decisions.
The team follows the client-approved escalation workflow, reinforces the provider-established action plan, and communicates with the appropriate treating clinician. Patients with emergency warning signs are directed to seek urgent or emergency care.
The team identifies cost and coverage concerns and helps coordinate appropriate formulary discussions, prescriber communication, pharmacy support, and available assistance resources.
Extend your teamโs reach with structured education, medication expertise, and coordinated follow-up.
